Annual Total Long Term Liabilities
$92.92 M
+$73.60 M+381.00%
December 31, 2023
Summary
- As of February 7, 2025, AUPH annual total long term liabilities is $92.92 million, with the most recent change of +$73.60 million (+381.00%) on December 31, 2023.
- During the last 3 years, AUPH annual total long term liabilities has risen by +$69.01 million (+288.56%).
- AUPH annual total long term liabilities is now at all-time high.
Performance
AUPH Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$82.75 M
+$740.00 K+0.90%
September 30, 2024
Summary
- As of February 7, 2025, AUPH quarterly total long term liabilities is $82.75 million, with the most recent change of +$740.00 thousand (+0.90%) on September 30, 2024.
- Over the past year, AUPH quarterly long term liabilities has increased by +$740.00 thousand (+0.90%).
- AUPH quarterly long term liabilities is now -12.85% below its all-time high of $94.95 million, reached on June 30, 2023.
Performance
AUPH Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
AUPH Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +381.0% | +0.9% |
| 3 y3 years | +288.6% | +258.2% |
| 5 y5 years | +257.0% | +258.2% |
AUPH Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +381.0% | -12.8% | +328.6% |
| 5 y | 5-year | at high | +545.0% | -12.8% | +474.4% |
| alltime | all time | at high | >+9999.0% | -12.8% | >+9999.0% |
Aurinia Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $82.75 M(+0.9%) |
| Jun 2024 | - | $82.01 M(-4.8%) |
| Mar 2024 | - | $86.11 M(-7.3%) |
| Dec 2023 | $92.92 M(+381.0%) | $92.92 M(+4.1%) |
| Sep 2023 | - | $89.25 M(-6.0%) |
| Jun 2023 | - | $94.95 M(+391.8%) |
| Mar 2023 | - | $19.31 M(-0.1%) |
| Dec 2022 | $19.32 M(-18.2%) | $19.32 M(-16.4%) |
| Sep 2022 | - | $23.10 M(-2.7%) |
| Jun 2022 | - | $23.75 M(-4.8%) |
| Mar 2022 | - | $24.94 M(+5.5%) |
| Dec 2021 | $23.63 M(-1.2%) | $23.63 M(-3.0%) |
| Sep 2021 | - | $24.36 M(-1.4%) |
| Jun 2021 | - | $24.70 M(-3.9%) |
| Mar 2021 | - | $25.70 M(+7.5%) |
| Dec 2020 | $23.91 M(+66.0%) | $23.91 M(-38.7%) |
| Sep 2020 | - | $39.02 M(-0.2%) |
| Jun 2020 | - | $39.10 M(+4.6%) |
| Mar 2020 | - | $37.39 M(+159.5%) |
| Dec 2019 | $14.41 M(-44.6%) | $14.41 M(+6.0%) |
| Sep 2019 | - | $13.59 M(-24.8%) |
| Jun 2019 | - | $18.07 M(-3.2%) |
| Mar 2019 | - | $18.66 M(-28.3%) |
| Dec 2018 | $26.03 M(+63.1%) | $26.03 M(+2.2%) |
| Sep 2018 | - | $25.47 M(+23.6%) |
| Jun 2018 | - | $20.61 M(+10.5%) |
| Mar 2018 | - | $18.64 M(+16.9%) |
| Dec 2017 | $15.95 M(+21.6%) | $15.95 M(-37.0%) |
| Sep 2017 | - | $25.33 M(-1.5%) |
| Jun 2017 | - | $25.71 M(-33.6%) |
| Mar 2017 | - | $38.72 M(+195.2%) |
| Dec 2016 | $13.12 M(+31.3%) | $13.12 M(+56.5%) |
| Sep 2016 | - | $8.38 M(+24.6%) |
| Jun 2016 | - | $6.73 M(-16.8%) |
| Mar 2016 | - | $8.08 M(-19.1%) |
| Dec 2015 | $9.99 M(-36.3%) | $9.99 M(-12.7%) |
| Sep 2015 | - | $11.44 M(-9.5%) |
| Jun 2015 | - | $12.65 M(-29.9%) |
| Mar 2015 | - | $18.05 M(+15.2%) |
| Dec 2014 | $15.67 M(+312.0%) | $15.67 M(+254.2%) |
| Sep 2014 | - | $4.42 M(+1.2%) |
| Jun 2014 | - | $4.37 M(+4.9%) |
| Mar 2014 | - | $4.17 M(+9.6%) |
| Dec 2013 | $3.80 M(+46.0%) | $3.80 M(-8.3%) |
| Sep 2013 | - | $4.15 M(+80.7%) |
| Jun 2013 | - | $2.30 M(-6.7%) |
| Mar 2013 | - | $2.46 M(-5.5%) |
| Dec 2012 | $2.61 M(-54.9%) | $2.61 M(+18.0%) |
| Sep 2012 | - | $2.21 M(-0.7%) |
| Jun 2012 | - | $2.22 M(-5.7%) |
| Mar 2012 | - | $2.36 M(-59.2%) |
| Dec 2011 | $5.78 M | $5.78 M(-5.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | $6.09 M(-4.6%) |
| Jun 2011 | - | $6.38 M(-1.1%) |
| Mar 2011 | - | $6.45 M(+149.1%) |
| Dec 2010 | $2.59 M(+73.4%) | $2.59 M(+74.3%) |
| Sep 2010 | - | $1.49 M(+15.2%) |
| Jun 2010 | - | $1.29 M(-12.3%) |
| Mar 2010 | - | $1.47 M(-1.5%) |
| Dec 2009 | $1.49 M(-84.5%) | $1.49 M(+2.2%) |
| Sep 2009 | - | $1.46 M(+49.5%) |
| Jun 2009 | - | $977.60 K(-72.4%) |
| Mar 2009 | - | $3.54 M(-63.4%) |
| Dec 2008 | $9.66 M(+175.1%) | $9.66 M(-7.3%) |
| Sep 2008 | - | $10.42 M(-24.6%) |
| Jun 2008 | - | $13.82 M(+314.3%) |
| Mar 2008 | - | $3.34 M(-5.0%) |
| Dec 2007 | $3.51 M(-0.8%) | $3.51 M(-1.0%) |
| Sep 2007 | - | $3.55 M(+5.6%) |
| Jun 2007 | - | $3.36 M(+3.8%) |
| Mar 2007 | - | $3.23 M(-8.7%) |
| Dec 2006 | $3.54 M(+44.7%) | $3.54 M(-13.2%) |
| Sep 2006 | - | $4.08 M(-0.1%) |
| Jun 2006 | - | $4.08 M(+103.7%) |
| Mar 2006 | - | $2.00 M(-18.2%) |
| Dec 2005 | $2.45 M(-34.0%) | $2.45 M(-3.8%) |
| Sep 2005 | - | $2.54 M(-13.2%) |
| Jun 2005 | - | $2.93 M(-14.3%) |
| Mar 2005 | - | $3.42 M(-7.8%) |
| Dec 2004 | $3.71 M(+599.6%) | $3.71 M(+6.7%) |
| Sep 2004 | - | $3.47 M(+757.5%) |
| Jun 2004 | - | $405.10 K(-11.5%) |
| Mar 2004 | - | $457.60 K(-13.6%) |
| Dec 2003 | $529.80 K(+311.0%) | $529.80 K(+121.1%) |
| Sep 2003 | - | $239.60 K(-23.0%) |
| Jun 2003 | - | $311.10 K(+176.8%) |
| Mar 2003 | - | $112.40 K(-12.8%) |
| Dec 2002 | $128.90 K(+125.3%) | $128.90 K(-18.8%) |
| Sep 2002 | - | $158.80 K(-21.0%) |
| Jun 2002 | - | $201.10 K(-10.4%) |
| Mar 2002 | - | $224.50 K(+624.2%) |
| Dec 2001 | $57.20 K(-1.4%) | - |
| Aug 2001 | - | $31.00 K(-24.4%) |
| May 2001 | - | $41.00 K(-18.2%) |
| Feb 2001 | - | $50.10 K(-13.6%) |
| Nov 2000 | $58.00 K(-14.6%) | $58.00 K(-21.6%) |
| Aug 2000 | - | $74.00 K(-44.6%) |
| May 2000 | - | $133.50 K(-3.1%) |
| Feb 2000 | - | $137.80 K(+102.9%) |
| Nov 1999 | $67.90 K(+4.3%) | $67.90 K(-66.2%) |
| Aug 1999 | - | $200.70 K(+196.0%) |
| May 1999 | - | $67.80 K(+2.3%) |
| Feb 1999 | - | $66.30 K |
| Nov 1998 | $65.10 K | - |
FAQ
- What is Aurinia Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Aurinia Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Aurinia Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of AUPH is $92.92 M
What is the all time high annual total long term liabilities for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual total long term liabilities is $92.92 M
What is Aurinia Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, AUPH annual total long term liabilities has changed by +$73.60 M (+381.00%)
What is Aurinia Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of AUPH is $82.75 M
What is the all time high quarterly long term liabilities for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly total long term liabilities is $94.95 M
What is Aurinia Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, AUPH quarterly total long term liabilities has changed by +$740.00 K (+0.90%)